Barclays
GDRX icon

Barclays’s GoodRx Holdings GDRX Stock Holding History

Barclays’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-97,500
Closed -$454K – 5179
2022
Q4 		$454K Buy
+97,500
New +$480K ﹤0.01% 3374

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Barclays's GDRX Position: Q2 2026 in Review

Barclays reduced its GoodRx Holdings (GDRX) stake by 4% in Q2 2026, selling an estimated $20.1K and leaving 191,656 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #3153.

Barclays first reported a position in GDRX in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.32M in Q3 2025. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Barclays held 191,656 shares of GoodRx Holdings worth $552K as of Q2 2026.
  • Barclays sold 7,899 GoodRx Holdings shares in Q2 2026, an estimated $20.1K.
  • GoodRx Holdings made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3153 holding.
  • Barclays first reported a position in GoodRx Holdings in Q1 2022 and has held it in 18 quarters since.
  • Barclays's GoodRx Holdings position peaked at $1.32M in Q3 2025.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.